IP Library › Granted Patent US 12,629,683
Granted Patent B2
US 12,629,683 · App. 17/200,538 · Granted May 19, 2026

Oligonucleotide encoded chemical libraries

Inventors: Kandaswamy Vijayan (San Diego, CA); Andrew Boyd Macconnell (San Diego, CA); Joseph Franklin Rokicki (Del Mar, CA); Michael Van Nguyen (San Diego, CA)
Assignee: Plexium, Inc.
B01L3/50853C12N15/1034C12N15/1065C12N15/1068C12N15/1075C12Q1/6869C12Q1/6876C40B30/04C40B30/06C40B50/04C40B50/14C40B50/16B01L2300/0829C12Q2600/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,629,683
App. No.
17/200,538
Filed
Mar 12, 2021
Granted
May 19, 2026
Kind
B2
Art Unit
1684
USPC
506/16
Abstract

This application provides a bead with a covalently attached chemical compound and a covalently attached DNA barcode and methods for using such beads. The bead has many substantially identical copies of the chemical compound and many substantially identical copies of the DNA barcode. The compound consists of one or more chemical monomers, where the DNA barcode takes the form of barcode modules, where each module corresponds to and allows identification of a corresponding chemical monomer. The nucleic acid barcode can have a concatenated structure or an orthogonal structure. Provided are method for sequencing the bead-bound nucleic acid barcode, for cleaving the compound from the bead, and for assessing biological activity of the released compound.

Claims (40)

1 . A bead complex comprising:

a bead;

a plurality of same compounds directly bound to the bead at a first position via a cleavable linker; and

directly bound to the bead at a second position different from the first position, in a sequential order:

a linker;

a primer directly bound to the linker;

an encoding region comprising a single-stranded DNA barcode, wherein the single-stranded DNA barcode is directly bound to the primer; and

a nucleic acid capturing group comprising a poly-T sequence, the nucleic acid capturing group being single-stranded and directly bound to the single-stranded DNA barcode, wherein:

the encoding region encodes a structure of each same compound of the plurality of same compounds or synthetic steps used to make the each corresponding same compound.

2 . The bead complex of claim 1 , wherein the cleavable linker comprises a photo-cleavable linker, an acid cleavable linker, a base cleavable linker, or a temperature cleavable linker.

3 . The bead complex of claim 1 , wherein the plurality of the same compounds each comprise multiple compound building blocks.

4 . The bead complex of claim 3 , wherein the encoding region encodes the synthetic steps used to make the each same compound.

5 . The bead complex of claim 1 , wherein the nucleic acid capturing group is configured to capture messenger RNA (mRNA).

6 . The bead complex of claim 1 , wherein the nucleic acid capturing group is configured to capture microRNA (miRNA).

7 . A plurality of bead complexes comprising a first bead complex and a second bead complex, the first bead complex comprising:

a first bead;

a first plurality of same compounds directly bound to the first bead at a first position via a first cleavable linker; and

directly bound to the first bead at a second position different from the first position, in a sequential order:

a linker;

a first primer directly bound to the first linker;

a first encoding region comprising a first single-stranded DNA barcode, wherein the first single-stranded DNA barcode is directly bound to the first primer; and

a first nucleic acid capturing group comprising a first poly-T sequence, the first nucleic acid capturing group being single-stranded and directly bound to the first single-stranded DNA barcode, wherein:

the first encoding region encodes a structure of each first same compound of the first plurality of same compounds or synthetic steps used to make the each first same compound; and the second bead complex comprising:

a second bead;

a second plurality of second same compounds directly bound to the second bead at a third position via a second cleavable linker; and

directly bound to the second bead at a fourth position different from the third position, in a sequential order:

a second linker;

a second primer directly bound to the second linker;

a second encoding region comprising a second single-stranded DNA barcode, wherein the second single-stranded DNA barcode is directly bound to the first primer; and

a second nucleic acid capturing group comprising a second poly-T sequence, the second nucleic acid capturing group being single-stranded and directly bound to the second single-stranded DNA barcode, wherein:

the second encoding region encodes a structure of each second same compound of the second plurality of same compounds or synthetic steps used to make the each second same compound, the second plurality of second same compounds are different from the first plurality of first same compounds, and the second single-stranded DNA barcode is different from the first single-stranded DNA barcode.

8 . The plurality of bead complexes of claim 7 , wherein the first cleavable linker comprises a photo-cleavable linker, an acid cleavable linker, a base cleavable linker, or a temperature cleavable linker.

9 . The plurality of bead complexes of claim 7 , wherein the first plurality of the first same compounds comprise multiple compound building blocks.

10 . The plurality of bead complexes of claim 7 , wherein the first nucleic acid capturing group is configured to capture messenger RNA (mRNA).

11 . The plurality of bead complexes of claim 7 , wherein the first nucleic acid capturing group is configured to capture microRNA (miRNA).

12 . The bead complex of claim 1 , wherein the each same first compound comprises a benzimidazole compound, imidazolidinone compound, quinazolinone compound, isoindolinone compound, thiazole compound, or an imidazopyridine compound.

13 . The bead complex of claim 1 , wherein the each same first compound comprises a lenalidomide or a stereoisomer or an enantiomer thereof.

14 . The bead complex of claim 1 , wherein the plurality of same compounds are screened for activity of inhibiting or activating a protein or a cellular function.

15 . The bead complex of claim 1 , wherein the plurality of same compounds comprise non-nucleic acid molecules.

16 . The bead complex of claim 1 , wherein the plurality of same compounds comprise amino acids.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2021
From: VIJAYAN, KANDASWAMY; MACCONNELL, ANDREW; ROKICKI, JOSEPH; VAN NGUYEN, MICHAEL
To: PLEXIUM, INC.
Reel/Frame 057083/0538 →
Continuity (5)
Division 16870809 · May 8, 2020
Division 16139831 · Sep 24, 2018
Provisional Application 62562912 · Sep 25, 2017
Provisional Application 62562905 · Sep 25, 2017
Related Publication 20220025358A1 · Jan 27, 2022
References Cited (199)
US 6001579A · Still et al. · 1999 [cited by applicant]
US 8551737B2 · Gumbrecht et al. · 2013 [cited by applicant]
US 8632975B2 · Vander Horn et al. · 2014 [cited by applicant]
US 8853185B2 · Barany et al. · 2014 [cited by applicant]
US 9347092B2 · Roesler et al. · 2016 [cited by applicant]
US 9902950B2 · Church · 2018 [cited by examiner]
US 10266874B2 · Weissleder et al. · 2019 [cited by applicant]
US 10946383B2 · Vijayan et al. · 2021 [cited by applicant]
US 10981170B2 · Vijayan et al. · 2021 [cited by applicant]
US 20040009583A1 · Benn et al. · 2004 [cited by applicant]
US 20050260101A1 · Nauck et al. · 2005 [cited by applicant]
US 20060134595A1 · Rapp et al. · 2006 [cited by applicant]
US 20070003442A1 · Link · 2007 [cited by examiner]
US 20070065844A1 · Golub et al. · 2007 [cited by applicant]
US 20120021940A1 · Guthold et al. · 2012 [cited by applicant]
US 20140378345A1 · Hindson et al. · 2014 [cited by applicant]
US 20150105553A1 · Barany et al. · 2015 [cited by applicant]
US 20160060687A1 · Zhu et al. · 2016 [cited by applicant]
US 20160067705A1 · Gehrig et al. · 2016 [cited by applicant]
US 20190085324A1 · Regev et al. · 2019 [cited by applicant]
US 20190093103A1 · Vijayan et al. · 2019 [cited by applicant]
US 20190210018A1 · Vijayan et al. · 2019 [cited by applicant]
US 20190358629A1 · Vijayan et al. · 2019 [cited by applicant]
US 20200001295A1 · Vijayan et al. · 2020 [cited by applicant]
US 20200199662A1 · Strauss · 2020 [cited by examiner]
US 20200324287A1 · Vijayan et al. · 2020 [cited by applicant]
CN 1108249A · 1995 [cited by applicant]
CN 1134156A · 1996 [cited by applicant]
CN 1193357A · 1998 [cited by applicant]
CN 1940088A · 2007 [cited by applicant]
CN 101505875A · 2009 [cited by applicant]
CN 101838696A · 2010 [cited by applicant]
CN 102485979A · 2012 [cited by applicant]
JP 2011516547A · 2011 [cited by applicant]
JP 2016525344A · 2016 [cited by applicant]
WO WO9320242A1 · 1993 [cited by applicant]
WO WO9512608A1 · 1995 [cited by applicant]
WO WO2009063462A2 · 2009 [cited by applicant]
WO WO2010151776A2 · 2010 [cited by examiner]
WO WO2012120514A2 · 2012 [cited by applicant]
WO WO2014200767A1 · 2014 [cited by applicant]
WO WO2014210353A2 · 2014 [cited by applicant]
WO WO2015164212A1 · 2015 [cited by examiner]
WO WO2016138184A1 · 2016 [cited by applicant]
WO WO2016183029A1 · 2016 [cited by applicant]
WO WO2017048975A1 · 2017 [cited by applicant]
WO WO2017075294A1 · 2017 [cited by applicant]
WO WO2018064640A1 · 2018 [cited by applicant]
WO WO2018089641A2 · 2018 [cited by applicant]
WO WO2019060830A1 · 2019 [cited by applicant]
WO WO2019060857A1 · 2019 [cited by applicant]
WO WO2019060830A9 · 2019 [cited by applicant]
Sharma (Med. Chem. Commun., 2014,5, 1454-1471). [cited by examiner]
Ebert et al., An Erythroid Differentiation Signature Predicts Response to Lenalidomide in Myelodysplastic Syndrome PLoS Medicine , 2008, 5(2), 1-11. (Year: 2008). [cited by examiner]
Mendes et al., High-Throughput Identification of DNA-Encoded IgG Ligands that Distinguish Active and Latent Mycobacterium Tuberculosis Infections, ACS Chemical Biology, 2016, 12, 234-243. (Year: 2016). [cited by examiner]
Itchaki et al., Lenalidomide in the Treatment of Chronic Lymphocytic Leukemia, Expert Opinion on Investigational Drugs, 2017, 26(5), 633-650. (Year: 2017). [cited by examiner]
Halford, Bethany, How DNA-Encoded Libraries are Revolutionizing Drug Discovery, Chemical & Engineering News, 2017, 95(25), 1-20. (Year: 2017). [cited by examiner]
U.S. Appl. No. 16/534,886, “Non-Final Office Action”, Oct. 21, 2019, 10 pages. [cited by applicant]
U.S. Appl. No. 16/534,922, “Non-Final Office Action”, Dec. 9, 2019, 9 pages. [cited by applicant]
Akerblom et al., “Six new photolabile linkers for solid-phase synthesis. 1. Methods of preparation”, Molecular Diversity, 3, 1998, pp. 137-148. [cited by applicant]
Akuffo et al., “Ligand-mediated protein degradation reveals functional conservation among sequence variants of the CUL4-type E3 ligase substrate receptor cereblon”, J. Biol. Chem. 293, 2018, pp. 6187-6200. [cited by applicant]
Alam et al., “DNA-binding peptides searched from the solid-phase combinatorial library with the use of the magnetic beads attaching the target duplex DNA”, Bioorg. Med. Chem. 8, 2000, pp. 465-473. [cited by applicant]
Angell et al., “Peptidomimetics via copper-catalyzed azide-alkyne cycloadditions”, Chem. Soc. Rev. 36, 2007, pp. 1674-1689. [cited by applicant]
Anton et al., “Optimization of radiation controlled gene expression by adenoviral vectors in vitro”, Cancer Gene Therapy 12, 2005, pp. 640-646. [cited by applicant]
Appell et al., “Biological screening of a large combinatorial library”, J. Biomolecular Screening 1(1), 1996, pp. 27-31. [cited by applicant]
Avital et al., “Seeing is believing: new methods for in situ single-cell transcriptomics”, Genome Biology. 15(110), 2014. 4 pages. [cited by applicant]
Baird et al., “Topoisomerase II drives DNA transport by hydrolyzing one ATP”, Proc. Nat'l. Acad. Sci. 96(24), 1999, pp. 13685-13690. [cited by applicant]
Baner et al., “Signal amplification of padlock probes by rolling circle replication”, Nucleic Acids Res. 26(22), 1998, pp. 5073-5078. [cited by applicant]
Banks et al., “L2DTL/CDT2 and PCNA Interact with p53 and Regulate p53 Polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 Complexes”, Cell Cycle 5, 2006, pp. 1719-1729. [cited by applicant]
Baruch et al., “Enzyme activity â€″ it's all about image”, Trends Cell Biology 14(1), 2004, pp. 29-35. [cited by applicant]
Bayer et al., “Biocytin hydrazide—a selective label for sialic acids, galactose, and other sugars in glycoconjugates using avidin-biotin technology”, Analyt. Biochem 170, 1988, pp. 271-281. [cited by applicant]
Bindels et al., “mScarlet: a bright monomeric red fluorescent protein for cellular imaging”, Nature Methods. 14(1), 2017, pp. 53-56. [cited by applicant]
Bohl et al., “Multi-layer SU-8 lift-off technology for microfluidic devices”, J. Micromechanics Microengineering. 15, 2005, pp. 1125-1130. [cited by applicant]
Bose et al., “Scalable microfluidics for single-cell RNA printing and sequencing”, Genome Biology 16(120), DOI 10.1186, 2015. 16 pages. [cited by applicant]
Boyer et al., “Adenovirus E4 34k and E4 11k inhibit double strand break repair and are physically associated with the cellular DNA-dependent protein kinase”, Virology 263, 1999, pp. 307-312. [cited by applicant]
Brenner et al., “Encoded combinatorial library”, Proc. Nat'l. Acad. Sci. 89, 1992, pp. 5381-5383. [cited by applicant]
Brouzes et al., “Droplet microfluidic technology for single-cell high-throughput screening”, Proc. Natl. Acad. Sci. 106, 2009, pp. 14195-14200. [cited by applicant]
Camperi et al., “An efficient strategy for the preparation of one-bead-one-peptide libraries on a new biocompatible solid support”, Tetrahedron Letters 46, 2005, pp. 1561-1564. [cited by applicant]
Carmona et al., “A continuous fluorescence resonance energy transfer angiotensin I-converting enzyme assay”, Nature Protocols 1(4), 2006, pp. 1971-1976. [cited by applicant]
Carr et al., “Reducing DNA context dependence in bacterial promoters”, PLoS One 12:e0176013, 2017. 15 pages. [cited by applicant]
Chamberlain et al., “Structure of the human Cereblon-DDB1-lenalidomide complex reveals basis for responsiveness to thalidomide analogs”, Nature Struct. Mol. Biol. 21(9), 2014, pp. 803-809. [cited by applicant]
Chen et al., “The Cullin 4A/B-DDB1-Cereblon E3 Ubiquitin Ligase Complex Mediates the Degradation of CLC-1 Chloride Channels”, Scientific Reports 5(10667), 2015. 13 pages. [cited by applicant]
Cho et al., “High-Throughput Screening of One-Beadâ€″One-Compound Peptide Libraries Using Intact Cells”, ACS Combinatorial Science 15, 2013, pp. 393-400. [cited by applicant]
Comellas et al., “Exploration of the one-bead one-compound methodology for the design of prolyl oligopeptidase substrates”, PLoS One 4(7), 2009, pp. e6222. 12 pages. [cited by applicant]
Dal Corso et al., “Protease-Cleavable Linkers Modulate the Anticancer Activity of Non-Internalizing Antibody-Drug Conjugates”, Bioconjugate Chemistry 28(7), 2017, pp. 1826-1833. [cited by applicant]
Decurtins, W. et al. (e-published Mar. 17, 2016, 2016). “Automated screening for small organic ligands using DNA-encoded chemical libraries.” Nature Protocols, 11(4), 764-780. [cited by applicant]
Del Campo et al., “SU-8: a photoresist for high-aspect-ratio and 3D submicron lithography”, J. Micromechanics Microengineering 17, 2007, pp. R81-R95. [cited by applicant]
Devaraj et al., “Fast and Sensitive Pretargeted Labeling of Cancer Cells via Tetrazine/Trans-Cyclooctene Cycloaddition”, Angew. Chem. Intl. 48(38), 2009, pp. 7013-7016. [cited by applicant]
Devy et al., “Plasmin-activated doxorubicin prodrugs containing a spacer reduce tumor growth and angiogenesis without systemic toxicity”, FASEB J. 18, 2004, pp. 565-567. [cited by applicant]
Doran et al., “Utility of redundant combinatorial libraries in distinguishing high and low quality screening hits”, ACS Combinatorial Science. 16, 2014, pp. 259-270. [cited by applicant]
Ekici et al., “Profiling the substrate specificity of viral protease VP4 by a FRET-based peptide library approach”, Biochemistry 48, 2009, pp. 5753-5759. [cited by applicant]
El Debs et al., “Functional single-cell hybridoma screening using droplet-based microfluidics”, Proc. Natl. Acad. Sci. 109, 2012, pp. 11570-11575. [cited by applicant]
Farzaneh et al., “ADP-ribosylation is involved in the integration of foreign DNA into the mammalian cell genome”, Nucleic Acids Res. 16(23), 1988, pp. 11319-11326. [cited by applicant]
Feng et al., “Fluorescence Logic-Signal-Based Multiplex Detection of Nucleases with the Assembly of a Cationic Conjugated Polymer and Branched DNA”, Angew Chem. Int. Ed. Engl. 48, 2009, pp. 5316-5321. [cited by applicant]
Fernandez Suarez et al., “Redirecting lipoic acid ligase for cell surface protein labeling with small-molecule probes”, Nature Biotechnol 25(12), 2007, pp. 1483-1487. [cited by applicant]
Gadkar et al., “New Developments in Quantitative Real-time Polymerase Chain Reaction Technology”, Curr. Issues Mol. Biol. 16, 2014, pp. 1-6. [cited by applicant]
Gandhi et al., “Measuring cereblon as a biomarker of response or resistance to lenalidomide and pomalidomide requires use of standardized reagents and understanding of gene complexity”, Brit. J. Haematol. 164, 2013, pp.… [cited by applicant]
Glatthar et al., “A New Photocleavable Linker in Solid-Phase Chemistry for Ether Cleavage”, Organic Letters 2, 2000, pp. 2315-2317. [cited by applicant]
Go et al., “Optimization and direct comparison of the dimerizer and reverse tet transcriptional control systems”, J Gene Med 4, 2002, pp. 258-270. [cited by applicant]
Gordon et al., “Solid phase synthesis â€″ designer linkers for combinatorial chemistry: a review”, J. Chemical Technology Biotechnology 74, 1999, pp. 835-851. [cited by applicant]
Guo et al., “Droplet microfluidics for high-throughput biological assays”, Lab Chip 12, 2012, pp. 2146-2155. [cited by applicant]
Han et al., “Fabrication of 3D Microstructures with Single uv Lithography Step”, J. Semiconductor Technology Science. 2, 2002, pp. 268-272. [cited by applicant]
Haun et al., “Bioorthogonal chemistry amplifies nanoparticle binding and enhances the sensitivity of cell detection”, Nature Nanotechnol 5(9), 2010, pp. 660-665. [cited by applicant]
Hilton et al., “An Assay to Monitor HIV-1 Protease Activity for the Identification of Novel Inhibitors in T-Cells”, PLoS One 5(6), 2010, e10940. 7 pages. [cited by applicant]
Holmes et al., “Model Studies for New o-Nitrobenzyl Photolabile Linkers: Substituent Effects on the Rates of Photochemical Cleavage”, J. Org. Chem. 62, 1997, pp. 2370-2380. [cited by applicant]
Holmes et al., “Reagents for Combinatorial Organic Synthesis: Development of a New o-Nitrobenzyl Photolabile Linker for Solid Phase Synthesis”, J. Org. Chem. 60, 1995, pp. 2318-2319. [cited by applicant]
Jenny et al., “A critical review of the methods for cleavage of fusion proteins with thrombin and factor Xa”, Protein Expression Purification 31, 2003, pp. 1-11. [cited by applicant]
Jeon et al., “Hot embossing for fabrication of a microfluidic 3D cell culture platform”, Biomed. Microdevices 13(2), 2011, pp. 325-333. [cited by applicant]
Jewett et al., “Cu-free click cycloaddition reactions in chemical biology”, Chem. Soc. Rev. 39(4), 2010, pp. 1272-1279. [cited by applicant]
Jia et al., “RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival”, Cell Division 4(16), D01:10.1186, 2009. 6 pages. [cited by applicant]
Johansson et al., “Choosing reporter-quencher pairs for efficient quenching”, Methods Mol. Biol. 335, 2006, pp. 17-29. [cited by applicant]
Kim et al., “High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice”, PLoS One 6(4), 2011, e18556. 8 pages. [cited by applicant]
Klein et al., “Droplet barcoding for single cell transcriptomics applied to embryonic stem cells”, Cell. 161, 2015, pp. 1187-1201. [cited by applicant]
Kohane et al., “Microparticles and nanoparticles for drug delivery”, Biotechnol. Bioeng. 96(2), 2007, pp. 203-209. [cited by applicant]
Kolb et al., “Click Chemistry: Diverse Chemical Function from a Few Good Reaction”, Angew. Chem. Int. Ed. 40, 2001, pp. 2004-2021. [cited by applicant]
Kolb et al., “The growing impact of click chemistry on drug discovery”, Drug Discovery Today 8, 2003, pp. 1128-1137. [cited by applicant]
Koppelhus et al., “Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid59 (CatLip) domain”, Bioconjug. Chem. 19, 2008, pp. 1526-1534. [cited by applicant]
Kronke et al., “Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS”, Nature 523(7559), 2015, pp. 183-188. [cited by applicant]
Lam et al., “The One-Bead-One-Compound Combinatorial Library Method”, Chem. Rev. 97, 1997, pp. 411-448. [cited by applicant]
Leriche et al., “Cleavable linkers in chemical biology”, Bioorganic Medicinal Chemistry 20, 2011, pp. 571-582. [cited by applicant]
Leslie et al., “The MDM2 Ring Domain and Central Acidic Domain Play Distinct Roles in MDM2 Protein Homodimerization and MDM2-MDMX Protein Heterodimerization”, J. Biol. Chem. 290, 2015, pp. 12941-12950. [cited by applicant]
Li et al., “Typing of Multiple Single-Nucleotide Polymorphisms by a Microsphere-Based Rolling Circle Amplification Assay”, Anal. Chem. 79, 2007, pp. 9030-9038. [cited by applicant]
Liu et al., “Fabrication of SU-8 moulds on glass substrates by using a common thin negative photoresist as an adhesive layer”, J. Micromechanics and Microengineering. 24:article ID:035009, 2014. 6 pages. [cited by applicant]
Liu et al., “High-Throughput Screening of One-Bead-One-Compound Libraries: Identification of Cyclic Peptidyl Inhibitors against Calcineurin/NFAT Interaction”, ACS Comb. Sci. 13, 2011, pp. 537-546. [cited by applicant]
Lood et al., “Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Forster resonance energy transfer (FRET)… [cited by applicant]
Lopez-Girona et al., “Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomide”, Leukemia 26, 2012, pp. 2326-2335. [cited by applicant]
Macconnell et al., “An integrated microfluidic processor for DNA-Encoded combinatorial library functional screening”, ACS Comb. Sci. 19, 2017, 181-192. [cited by applicant]
Macconnell et al., “DNA-Encoded solid-phase synthesis: Encoding language design and complex oligomer library synthesis”, ACS Comb. Sci. 17, 2015, pp. 518-534. [cited by applicant]
Macconnell et al., “Poisson statistics of combinatorial library sampling predict false discovery rates of screening”, ACS Comb. Sci. 19, 2017, pp. 524-532. [cited by applicant]
Maltman et al., “Enzyme-cleavable linkers for peptide and glycopeptide synthesis”, Organic Biomolecular Chem. 3, 2005, pp. 2505-2507. [cited by applicant]
Matyskiela et al., “A novel cereblon modulator recruits GSPT1 to the CRL4(CRBN) ubiquitin ligase”, Nature 535, 2016, pp. 252-257. [cited by applicant]
Meldal et al., “Cu-Catalyzed Azide-Alkyne Cycloaddition”, Chem. Rev. 108, 2008, pp. 2952-3015. [cited by applicant]
Mendes et al., “High-throughput identification of DNA encoded IgG ligands that distinguish active and latent [cited by applicant]
Meng et al., “Screening of HIV-1 Protease Using a Combination of an Ultra-High-Throughput Fluorescent-Based Assay and RapidFire Mass Spectrometry”, J. Biomolecular Sensing 20(5), 2015, pp. 606-615. [cited by applicant]
Mikkelsen et al., “Photolabile Linkers for Solid-Phase Synthesis”, ACS Combinatorial Science. D01:10.1021, 2018, pp. 377-399. [cited by applicant]
Minetti et al., “The thermodynamics of template-directed DNA synthesis: base insertion and extension enthalpies”, Proc. Natl. Acad. Sci. 100, 2003, pp. 14719-14724. [cited by applicant]
Nag et al., “Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53”, Cancer Res. 64, 2004, pp. 8152-8155. [cited by applicant]
Nilsson et al., “Real-time monitoring of rolling-circle amplification using a modified molecular beacon design”, Nucleic Acids Res. 30, 2002, e66. 7 pages. [cited by applicant]
Oh et al., “Integrated Nanoplasmonic Sensing for Cellular Functional Immunoanalysis Using Human Blood”, ACS Nano 8(3), 2014, pp. 2667-2676. [cited by applicant]
Oldenburg et al., “Assay Miniaturization for Ultra-High Throughput Screening of Combinatorial and Discrete Compound Libraries: A 9600-Well (0.2 Microliter) Assay System”, Journal of Biomolecular Screening, vol. 3, No. 1… [cited by applicant]
Olejnik et al., “Photocleavable peptide-DNA conjugates: synthesis and applications to DNA analysis using MALDI-MS”, Nucleic Acids Res. 27(23), 1999, pp. 4626-4631. [cited by applicant]
Ortiz et al., “Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes”, Oncogene 37, 2018, pp. 332-340. [cited by applicant]
Ostrander et al., “Construction of small-insert genomic DNA libraries highly enriched for microsatellite repeat sequences”, Proc. Natl. Acad. Sci. 89, 1992, pp. 3419-3423. [cited by applicant]
Pabinger et al., “A survey of tools for the analysis of quantitative PCR (qPCR) data”, Biomolecular Detection Quantification 1, 2010, pp. 23-33. [cited by applicant]
Paulick et al., “Cleavable hydrophilic linker for one-bead-one-compound sequencing of oligomer libraries by tandem mass spectrometry”, J. Comb. Chem. 8, 2006, pp. 417-426. [cited by applicant]
PCT/US2018/052438 “International Search Report and Written Opinion”, Feb. 4, 2019, 25 pages. [cited by applicant]
PCT/US2018/052497 “International Search Report and Written Opinion”, Jan. 22, 2019, 29 pages. [cited by applicant]
Perry et al., “Development of plastic microwell arrays for improved replication fidelity”, 18th Int. Conference on Miniaturized Systems for Chemistry and Life Sciences Oct. 26-30, 2014, San Antonio, TX, 2014, pp. 1701-1… [cited by applicant]
Price et al., “Discovery in droplets”, Analyt. Chem. 88, 2016, pp. 339-353. [cited by applicant]
Price et al., “hvSABR: Photochemical dose-response bead screening in droplets”, Analyt. Chem. 88, 2016, pp. 2904-2911. [cited by applicant]
Price et al., “Microfluidic bead suspension hopper”, Analyt. Chem. 86, 2014, 5039-5044. [cited by applicant]
Qian et al., “An Isotopically Tagged Azobenzene-Based Cleavable Linker for Quantitative Proteomics”, ChemBioChem 14, 2013, pp. 1410-1414. [cited by applicant]
Rahim et al., “Enhancing Reactivity for Bioorthogonal Pretargeting by Unmasking Antibody Conjugated trans-Cyclooctenes”, Bioconjug. Chem. 26(2), 2015, pp. 352-360. [cited by applicant]
Ramya et al., “Glycoproteomics enabled by tagging sialic acid- or galactose-terminated glycans”, Glycobiology 23(2), 2013, pp. 211-221. [cited by applicant]
Rasooly et al., “Development of an In Vitro Activity Assay as an Alternative to the Mouse Bioassay for Clostridium botulinum Neurotoxin Type A”, Appl. Environ. Microbiol. 74(14), 2008, pp. 4309-4313. [cited by applicant]
Refsland et al., “Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction”, Nucleic Acids Res. 38(13), 2010, pp. 4274-4284. [cited by applicant]
Reisfeld et al., “Nonradioactive hybridization probes prepared by the reaction of biotin hydrazide with DNA”, Biochem. Biophys. Res. Commun. 142(2), 1987, pp. 519-526. [cited by applicant]
Renil et al., “Synthesis of fully Protected Peptides on a Tetraethyleneglycol Diacrylate (TTEGDA)-Crosslinked Polystyrene support with a Photolytically Detachable 2-Nitrobenzyl Anchoring group”, Tetrahedron Lett. 35(22)… [cited by applicant]
Rich et al., “Preparation of a new o-nitrobenzyl resin for solid-phase synthesis of tert- butyloxycarbonyl-protected peptide acids”, J. Am. Chem. Soc. 97(6), 1975, pp. 1575-1579. [cited by applicant]
Rohr et al., “Role ofIGF-1 in Primary Ovarian Cancer—A Study of the OVCAD European Consortium”, Anticancer Res. 36, 2016, pp. 1015-1022. [cited by applicant]
Saliba et al., “Single-cell RNA-seq: advances and future challenges”, Nucleic Acids Res. 42(14), 2014, pp. 8845-8860. [cited by applicant]
Saran et al., “A Versatile Photocleavable Bifunctional Linker for Facile Synthesis of Substrate-DNA Conjugates for the Selection of Nucleic Acid Catalysts”, Bioconguate Chem. 18, 2007, pp. 275-279. [cited by applicant]
Satz et al., “DNA Compatible Multistep Synthesis and Applications to DNA Encoded Libraries”, Bioconjugate Chemistry 26, 2015, pp. 1623-1632. [cited by applicant]
Schafer et al., “Cereblon modulator iberdomide induces degradation of the transcription factors Ikaros and Aiolos: immunomodulation in healthy volunteers and relevance to systemic lupus erythematosus”, Ann. Rheum. Dis. … [cited by applicant]
Sciambi et al., “Accurate microfluidic sorting of droplets at 30KHz”, Lab Chip 15(1), 2015, pp. 47-51. [cited by applicant]
Sepetov et al., “Library of libraries: approach to synthetic combinatorial library design and screening of “pharmacophore” motifs”, Proc. Natl. Acad. Sci. 92, 1995, pp. 5426-5430. [cited by applicant]
Shearer et al., “Functional Roles of the E3 Ubiquitin Ligase UBR5 in Cancer”, Molecular Cancer Res. 13, 2015, pp. 1523-1532. [cited by applicant]
Shih et al., “A Novel Galectin-1 Inhibitor Discovered through One-Bead Two-Compound Library Potentiates the Antitumor Effects of Paclitaxel in vivo”, Mol. Cancer Ther. 16(7), 2017, pp. 1212-1223. [cited by applicant]
Singh et al., “Microencapsulation: A promising technique for controlled drug delivery”, Res Pharm Sci. 5(2), 2010, pp. 65-77. [cited by applicant]
Song et al., “A novel and rapid encoding method based on mass spectrometry for “one-bead-one-compound” small molecule combinatorial libraries”, J. Am. Chem. Soc. 125, 2003, pp. 6180-6188. [cited by applicant]
Spackova et al., “Optical Biosensors Based on Plasmonic Nanostructures: A Review”, Proceedings of the IEEE 104(12), 2016, pp. 2380-2408. [cited by applicant]
Stefflova et al., “Using molecular beacons for cancer imaging and treatment”, Frontiers Bioscience 12, 2007, pp. 4709-4721. [cited by applicant]
Stockwell et al., “Frontiers in chemical genetics”, Trends Biotechnol. 18, 2000, pp. 449-455. [cited by applicant]
Stope et al., “Drug-induced Modulation of Heat Shock Protein HSPB1 in an Ovarian Cancer Cell Model”, Anticancer Res. 36, 2016, pp. 3321-3327. [cited by applicant]
Szymonifka et al., “The preparation of magnetite-impregnated polymeric supports for use in solid phase organic synthesis is described”, Tetrahedron Letters 36(10), 1995, pp. 1597-1600. [cited by applicant]
Tang et al., “Suppression of artifacts and barcode bias in high-throughput transcriptome analyses utilizing template switching”, Nucleic Acids Res. 41(3), 2013, e44 (12 pages). [cited by applicant]
Tsourkas et al., “Hybridization kinetics and thermodynamics of molecular beacons”, Nucleic Acids Res. 15(4), 2003, pp. 1319-1330. [cited by applicant]
Turner et al., “Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells”, Nucleic Acids Research 33(21), 2005, pp. 6837-6849. [cited by applicant]
Tyagi et al., “Molecular beacons: probes that fluoresce upon hybridization”, Nature Biotechnol 14, 1996, pp. 303-308. [cited by applicant]
Van Buggenum et al., “A covalent and cleavable antibody-DNA conjugation strategy for sensitive protein detection via immuno-PCR”, Scientific Reports. 6:22675, 2016. 12 pages. [cited by applicant]
Whitehouse et al., “An Improved Synthesis and Selective Coupling of a Hydroxy Based Photolabile Linker for Solid Phase Organic Synthesis”, Tetrahedron Lett. 38(45), 1997, pp. 7851-7852. [cited by applicant]
Wilczewska et al., “Nanoparticles as drug delivery systems”, Pharmacological Reports 2012(64), 2012, pp. 1020-1037. [cited by applicant]
Wollscheid et al., “Mass-spectrometric identification and relative quantification of N-linked cell surface glycoproteins”, Nature Biotechnol 27(4), 2009, pp. 378-386. [cited by applicant]
Wu et al., “Targeting RING domains of Mdm2-MdmX E3 complex activates apoptotic arm of the p53 pathway in leukemia/lymphoma cells”, Cell Death Disease 6, 2015, e 2035. 10 pages. [cited by applicant]
Yang et al., “Cereblon suppresses the lipopolysaccharide-induced inflammatory response by promoting the ubiquitmation and degradation of c-Jun”, J. Biol. Chem. 293(26), 2018, pp. 10141-10157. [cited by applicant]
Yang, “Design of Cleavable Linkers and Applications in Chemical Proteomics. Technische Universitat Munchen Lehrstuhl fur Chemie der Biopolymere”, 2014. 132 pages. [cited by applicant]
Yoo et al., “Synthesis of Oligonucleotides Containing 3′-Alkyl Carboxylic Acids Using Universal, Photolabile Solid Phase Synthesis Supports”, J. Org. Chem. 60, 1995, pp. 3358-3364. [cited by applicant]
Zhu et al., “Detecting cytokine release from single T-cells”, Anal. Chem. 81(19), 2009, pp. 8150-8156. [cited by applicant]
Zhu et al., “Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma”, Blood 124, 2014, pp. 536-545. [cited by applicant]
Ziegenhain et al., “Comparative analysis of single-cell RNA sequencing methods”, Molecular Cell. 65, 2017, pp. 631-643. [cited by applicant]
Zimmermann et al., “Hartwig-Buchwald Amination on Solid Supports: a Novel Access to a Diverse Set of 1H-Benzotriazoles”, J. Comb. Chem. 9, 2007, pp. 1114-1137. [cited by applicant]
Chu et al., “Cell Surface Self-Assembly of Hybrid Nanoconjugates via Oligonucleotide Hybridization Induces Apoptosis,” ACS Nano, 8(1), 2014, pp. 719-730. [cited by applicant]
Extended European Search Report, dated Oct. 15, 2021, regarding EP Application No. 18859564.9, 15 pages. [cited by applicant]
Hahn et al., “Microsystem for Field-Amplified Electrokinetic Trapping Preconcentration of DNA at Poly(ethylene terephthalate) Membranes,” Analytical Chemistry, 81(8), 2009, pp. 2904-2911. [cited by applicant]
Heath et al., “Single-cell analysis tools for drug discovery and development,” Nature Reviews Drug Discovery, 15(3), 2016, pp. 204-216. [cited by applicant]
International Search Report, dated Jun. 9, 2021, regarding International Application No. PCT/US21/15550, 4 pages. [cited by applicant]
Macosko et al., “Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets,” Cell, 161(5), 2015, pp. 1202-1214. [cited by applicant]
Shembekar et al., “Droplet-based microfluidics in drug discovery, transcriptomics and high-throughput molecular genetics,” Lab Chip, 16(8), 2016, pp. 1314-1331. [cited by applicant]
Wagner et al., “DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety,” Bioconjugate Chemistry, 4(1), 1991… [cited by applicant]